Immix Biopharma, Inc.
IMMX
$2.00
-$0.12-5.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -51.46% | -45.70% | 0.98% | 0.55% | 89.47% |
| Total Receivables | -- | -- | 68.44% | 202.74% | 566.77% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -56.70% | -50.60% | -52.02% | -45.42% | -50.34% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 30.15% | -3.88% | -27.58% | -78.14% | -- |
| Total Current Assets | -54.90% | -49.02% | 2.07% | 1.90% | 76.25% |
|
|
|||||
| Total Current Assets | -54.90% | -49.02% | 2.07% | 1.90% | 76.25% |
| Net Property, Plant & Equipment | 114.09% | 119.02% | 5,337.45% | 5,799.25% | 59,288.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 542.16% | 0.00% | -76.61% | -80.23% | -64.02% |
| Total Assets | -45.78% | -42.09% | 15.17% | 11.87% | 85.24% |
|
|
|||||
| Total Accounts Payable | 181.87% | 63.45% | 276.03% | 110.00% | -2.06% |
| Total Accrued Expenses | 120.65% | 65.79% | 41.27% | 155.12% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 45.66% | 97.67% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 156.53% | 64.53% | 133.41% | 132.33% | 62.86% |
|
|
|||||
| Total Current Liabilities | 156.53% | 64.53% | 133.41% | 132.33% | 62.86% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.76% | -6.40% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 122.10% | 53.35% | 160.54% | 168.65% | 106.38% |
|
|
|||||
| Common Stock & APIC | 4.53% | 3.06% | 26.65% | 28.65% | 51.76% |
| Retained Earnings | -36.67% | -35.62% | -40.47% | -45.30% | -43.19% |
| Treasury Stock & Other | -305.29% | -720.39% | -391.07% | 273.12% | 189.01% |
| Total Common Equity | -80.52% | -65.63% | -19.23% | -11.24% | 80.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -80.52% | -65.63% | -19.23% | -11.24% | 80.62% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -80.52% | -65.28% | -18.22% | -10.68% | 81.40% |
|
|
|||||